557 related articles for article (PubMed ID: 32053883)
1. Use of Botulinum Toxin in Orofacial Clinical Practice.
Serrera-Figallo MA; Ruiz-de-León-Hernández G; Torres-Lagares D; Castro-Araya A; Torres-Ferrerosa O; Hernández-Pacheco E; Gutierrez-Perez JL
Toxins (Basel); 2020 Feb; 12(2):. PubMed ID: 32053883
[TBL] [Abstract][Full Text] [Related]
2. A critical review of the use of botulinum toxin in orofacial pain disorders.
Clark GT; Stiles A; Lockerman LZ; Gross SG
Dent Clin North Am; 2007 Jan; 51(1):245-61, ix. PubMed ID: 17185069
[TBL] [Abstract][Full Text] [Related]
3. Effects of Botulinum Toxin Type A on Pain among Trigeminal Neuralgia, Myofascial Temporomandibular Disorders, and Oromandibular Dystonia.
Yoshida K
Toxins (Basel); 2021 Aug; 13(9):. PubMed ID: 34564609
[TBL] [Abstract][Full Text] [Related]
4. Botulinum toxin in the treatment of rare head and neck pain syndromes: a systematic review of the literature.
Sycha T; Kranz G; Auff E; Schnider P
J Neurol; 2004 Feb; 251 Suppl 1():I19-30. PubMed ID: 14991339
[TBL] [Abstract][Full Text] [Related]
5. Botulinum Toxin Type A in Dental Medicine.
Muñoz Lora VRM; Del Bel Cury AA; Jabbari B; Lacković Z
J Dent Res; 2019 Dec; 98(13):1450-1457. PubMed ID: 31533008
[TBL] [Abstract][Full Text] [Related]
6. Effects of botulinum toxin in patients with myofascial pain related to temporomandibular joint disorders: A systematic review.
Ramos-Herrada RM; Arriola-Guillén LE; Atoche-Socola KJ; Bellini-Pereira SA; Castillo AA
Dent Med Probl; 2022; 59(2):271-280. PubMed ID: 35775414
[TBL] [Abstract][Full Text] [Related]
7. Mechanism and clinical use of botulinum neurotoxin in head and facial region.
Raman S; Yamamoto Y; Suzuki Y; Matsuka Y
J Prosthodont Res; 2023 Oct; 67(4):493-505. PubMed ID: 36740263
[TBL] [Abstract][Full Text] [Related]
8. The therapeutic use of botulinum toxin in cervical and maxillofacial conditions: an evidence-based review.
Ihde SK; Konstantinovic VS
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Aug; 104(2):e1-11. PubMed ID: 17560141
[TBL] [Abstract][Full Text] [Related]
9. Is low dose of botulinum toxin effective in controlling chronic pain in sleep bruxism, awake bruxism, and temporomandibular disorder?
de Lima MC; Rizzatti Barbosa CM; Duarte Gavião MB; Ferreira Caria PH
Cranio; 2024 Jul; 42(4):421-428. PubMed ID: 34488556
[TBL] [Abstract][Full Text] [Related]
10. Botulinum neurotoxin injections for muscle-based (dystonia and spasticity) and non-muscle-based (neuropathic pain) pain disorders: a meta-analytic study.
Siongco PRL; Rosales RL; Moore AP; Freynhagen R; Arimura K; Kanovsky P; Kaji R; Fernandez HH; Dressler D
J Neural Transm (Vienna); 2020 Jun; 127(6):935-951. PubMed ID: 32146504
[TBL] [Abstract][Full Text] [Related]
11. Temporomandibular Myofacial Pain Treated with Botulinum Toxin Injection.
Mor N; Tang C; Blitzer A
Toxins (Basel); 2015 Jul; 7(8):2791-800. PubMed ID: 26213970
[TBL] [Abstract][Full Text] [Related]
12. Botulinum Toxin for Neuropathic Pain: A Review of the Literature.
Oh HM; Chung ME
Toxins (Basel); 2015 Aug; 7(8):3127-54. PubMed ID: 26287242
[TBL] [Abstract][Full Text] [Related]
13. Treatment of temporomandibular disorders with botulinum toxin.
Schwartz M; Freund B
Clin J Pain; 2002; 18(6 Suppl):S198-203. PubMed ID: 12569969
[TBL] [Abstract][Full Text] [Related]
14. Clinical use of botulinum toxins in oral and maxillofacial surgery.
Majid OW
Int J Oral Maxillofac Surg; 2010 Mar; 39(3):197-207. PubMed ID: 19959337
[TBL] [Abstract][Full Text] [Related]
15. Is Botulinum Toxin Effective in Treating Orofacial Neuropathic Pain Disorders? A Systematic Review.
Val M; Delcanho R; Ferrari M; Guarda Nardini L; Manfredini D
Toxins (Basel); 2023 Sep; 15(9):. PubMed ID: 37755967
[TBL] [Abstract][Full Text] [Related]
16. Botulinum toxin therapy for temporomandibular joint disorders: a systematic review of randomized controlled trials.
Chen YW; Chiu YW; Chen CY; Chuang SK
Int J Oral Maxillofac Surg; 2015 Aug; 44(8):1018-26. PubMed ID: 25920597
[TBL] [Abstract][Full Text] [Related]
17. Botulinum toxin type A applications for masticatory myofascial pain and trigeminal neuralgia: what is the evidence regarding adverse effects?
De la Torre Canales G; Poluha RL; Lora VM; Araújo Oliveira Ferreira DM; Stuginski-Barbosa J; Bonjardim LR; Cury AADB; Conti PCR
Clin Oral Investig; 2019 Sep; 23(9):3411-3421. PubMed ID: 31342244
[TBL] [Abstract][Full Text] [Related]
18. Application of botulinum toxin in pregnancy and its impact on female reproductive health.
Li W; Tang M
Expert Opin Drug Saf; 2020 Jan; 19(1):83-91. PubMed ID: 31868020
[No Abstract] [Full Text] [Related]
19. Botulinum Toxin for the Treatment of Neuropathic Pain.
Park J; Park HJ
Toxins (Basel); 2017 Aug; 9(9):. PubMed ID: 28837075
[TBL] [Abstract][Full Text] [Related]
20. Botulinum toxin for myofascial pain syndromes in adults.
Soares A; Andriolo RB; Atallah AN; da Silva EM
Cochrane Database Syst Rev; 2014 Jul; 2014(7):CD007533. PubMed ID: 25062018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
